期刊文献+

儿童脓毒症的诊断进展 被引量:4

Progress in the diagnosis of sepsis in children
下载PDF
导出
摘要 脓毒症的早期诊断与治疗一直是儿科危重症的焦点问题。近年世界卫生组织(WHO)提出了“预防、诊断和临床处理一体化干预”的理念,我国急诊领域一批权威专家也率先提出了“预防脓毒症行动”(PSCC),但如何在临床工作中有效协调处理好相关问题,尤其是如何做到早期精准诊断并为后期采取集束化策略精准救治还是需要积极关注的热点问题。本文综述了儿童脓毒症的生物标志物、多维评分方法及具有诊断意义的生理参数与变量、机器脓毒症预测系统等诊断手段的最新研究及相关进展,以期将来为儿童脓毒症的早期诊断及精准治疗提供参考,为临床医生提供帮助。 The early diagnosis and treatment of sepsis has always been the focus of pediatric critical illness.In recent years,the World Health Organization(WHO)bring forth the concept of“integrated intervention of prevention,diagnosis and clinical treatment”.A group of authoritative experts in the field of emergency treatment in China have also taken the lead in projecting the“prevention of sepsis campaign in China”(PSCC),but how to effectively coordinate and deal with relevant issues in clinical work,especially how to make early accurate diagnosis and take bundle strategy of intensive treatment for the later stage is still a hot issue that needs active attention.In this paper,some new reaearch and related progress of the diagnostic methods of children sepsis,such as biomarkers,multi-dimensional scoring methods,physiological parameters and variables of diagnostic significance,and the prediction system of mechanical sepsis are reviewed in order to provide reference for early diagnosis and accurate treatment of children sepsis in the future,and to offer assistance for clinicians.
作者 林小飞 顾小海 于春琳 朱红利 吴云朵 张军 王玉美 LIN Xiaofei;GU Xiaohai;YU Chunlin;ZHU Hongli;WU Yunduo;ZHANG Jun;WANG Yumei(Department of Pediatrics,the Huai’an Maternity and Child Clinical College of Xuzhou Medical University,Jiangsu Province,Huai’an223002,China;Neonatal Disease Screening Center,the Huai’an Maternity and Child Clinical College of Xuzhou Medical University,Jiangsu Province,Huai’an223002,China)
出处 《中国医药导报》 CAS 2021年第4期45-48,60,共5页 China Medical Herald
基金 江苏省妇幼健康科研项目(F201940) 江苏省卫生健康委员会高层次人才“六个一工程”拔尖人才科研项目(LGY2018044) 江苏省淮安市科学技术局科研立项项目(HAB201825)。
关键词 儿童 脓毒症 诊断 进展 Children Sepsis Diagnosis Progress
  • 相关文献

参考文献13

二级参考文献83

  • 1杨公炜,汪明明,徐皖苏.血清降钙素原检测在临床中的应用[J].医学综述,2005,11(9):841-843. 被引量:43
  • 2吴跃平,章文,陈运生,徐刚,陈月生.儿童血培养病原菌分布及耐药性分析[J].中华医院感染学杂志,2006,16(4):463-465. 被引量:35
  • 3樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 4王强,霍飞,战忠丽.吉林防汛决策支持系统研制与开发[J].农业网络信息,2006(10):15-18. 被引量:3
  • 5Dellinger RP, Levy MM, Cadet JM, et al. Surviving sepsis cam- paign : international guidelines form anagement of severe sepsis and septic shock:2008[J]. Crit Care Med, 2008, 34 ( 1 ) : 17-60. DOI : 10. 3109/14767058. 2011. 601923. 被引量:1
  • 6Carvalho PRA, Feldens L, Seitz EE, et al. Prevalence of systemic in-flammatory syndromes at a tertiary pediatric intensive care unit[ J]. J Pedialr( Rio J), 2005, 81 (2) : 143-148. 被引量:1
  • 7Masson S, Caironi P, Fanizza C, et al. Circulating presepsin ( soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial [ J]. Intensive Care Med, 2015, 41 (9) : 1736. DOI:10. 1007/s00134-015-3982-z. 被引量:1
  • 8Gliick T, Silver J, Epstein M, et al. Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis [J]. EurJMedRes, 2001, 6(8):351-358. 被引量:1
  • 9Pavcnik-Amol M, Hojker S, Derganc M. Lipopo-lysaceharide- binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children [ J ]. Intensive Care Med, 2007, 33(6) : 1025-1032. DOI:10. 1007/s00134-007-O626-y. 被引量:1
  • 10Mussap M, Puxeddu E, Puddu M, et al. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS[J]. Clin Chim Acta, 2015, 451 (Pt A) : 65-70. DOI:I0. 1016/j. cca. 2015.07. 025. 被引量:1

共引文献150

同被引文献94

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部